Heart rate, age and the risk of progression to kidney failure in patients with CKD

被引:10
|
作者
Zoccali, Carmine [1 ]
Leonardis, Daniela
Enia, Giuseppe
Postorino, Maurizio
D'Arrigo, Graziella
Tripepi, Giovanni
Mallamaci, Francesca
机构
[1] Osped Riuniti Reggio Calabria, CNR IBIM, I-89124 Reggio Di Calabria, Italy
关键词
Age; Chronic kidney disease; CKD progression; Heart rate; CARDIOVASCULAR-DISEASE; SYMPATHETIC HYPERACTIVITY; RENAL-FAILURE; BETA-BLOCKERS; HYPERTENSION; NEPHROLOGY;
D O I
10.5301/jn.5000229
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and methods: Since heart rate (HR) is a cardiovascular risk factor and a marker of sympathetic activity, we tested the predictive value of HR for progression to kidney failure in a well characterized cohort of 759 patients with stage 2-5 CKD followed up for 29 11 months. Results: Overall, a total of 244 patients had renal events. In an unadjusted analysis by age tertiles the predictive value of HR for renal events was apparent only in patients in the third age tertile (older than 68 years) but not in those in the first two tertiles indicating effect modification by age of the HR - progression to kidney failure relationship. In a multiple Cox regression model adjusting for potential confounders, a 5 beats/min increase in HR entailed a 16 % risk excess (Hazard Ratio = 1.16, P = .004) for renal events in patients in the third age tertile but no excess risk for the same events in patients in the first two tertiles. A statistically significant interaction (P<.001) was also found between age and the risk for renal events associated with proteinuria. Conclusions: Heart rate is an independent age-dependent effect modifier for progression to kidney failure in CKD patients. This observation generates the hypothesis that high sympathetic activity is a relevant risk factor for adverse renal outcomes in elderly patients with CKD.
引用
收藏
页码:S20 / S27
页数:8
相关论文
共 50 条
  • [1] Cardiorenal Syndrome and Kidney Disease Progression in Patients With Heart Failure or CKD: Is the Heart Leading the Way?
    Santos Araujo, Carla Alexandra R.
    Mendonca, Luis C.
    Seabra, Daniel
    Bernardo, Filipa
    Pardal, Marisa
    Couceiro, Joao
    Martinho, Hugo M.
    Dias, Daniel
    Dinis-Oliveira, Ricardo J.
    Gavina, Cristina
    Gomes, Tiago Taveira
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 225 - 225
  • [2] Urinary Peptidome Analysis to Predict the Risk of CKD Progression to Kidney Failure
    Massy, Ziad
    Lambert, Oriane
    Metzger, Marie
    Sedki, Mohammed
    Glorieux, Griet L.
    Verbeke, Francis
    Mischak, Harald
    Siwy, Justyna
    Stengel, Benedicte
    Schanstra, Joost
    Klein, Julie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 723 - 723
  • [3] Empagliflozin improves kidney outcomes in patients with heart failure and CKD
    Carney, Ellen F.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (01) : 14 - 14
  • [4] Empagliflozin improves kidney outcomes in patients with heart failure and CKD
    Ellen F. Carney
    Nature Reviews Nephrology, 2021, 17 : 14 - 14
  • [5] The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD
    Hundemer, Gregory L.
    Tangri, Navdeep
    Sood, Manish M.
    Clark, Edward G.
    Canney, Mark
    Edwards, Cedric
    White, Christine A.
    Oliver, Matthew J.
    Ramsay, Tim
    Akbari, Ayub
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (12): : 2993 - 3001
  • [6] The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD
    Hundemer, Gregory L.
    Tangri, Navdeep
    Sood, Manish M.
    Akbari, Ayub
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 21 - 21
  • [7] Prediction of CKD progression with Kidney Failure Risk Equation - evaluation of a Portuguese cohort
    Pereira, Rita Lages
    Machado, Sara
    Moreira, Celia
    Correia-Costa, Liane
    Teixeira, Ana
    Rocha, Liliana
    Matos, Paula
    Costa, Teresa
    Faria, Maria Sameiro
    Mota, Conceicao
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S66 - S66
  • [8] Validation of the kidney failure risk equation in European CKD patients
    Peeters, Mieke J.
    van Zuilen, Arjan D.
    van den Brand, Jan A. J. G.
    Bots, Michiel L.
    Blankestijn, Peter J.
    Wetzels, Jack F. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (07) : 1773 - 1779
  • [9] Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD
    Sy-Go, Janina Paula T.
    Moubarak, Simon
    Vaughan, Lisa E.
    Klomjit, Nattawat
    Viehman, Jason K.
    Fervenza, F. C.
    Zand, Ladan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (03): : 319 - 328
  • [10] Race and the Risk of Heart Failure in CKD
    Hartsell, Sydney E.
    Ye, Xiangyang
    Boucher, Robert E.
    Sarwal, Amara
    Wei, Guo
    Beddhu, Srinivasan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 249 - 249